Avacta Group PLC banner

Intrinsic Value

Is AVCT undervalued or overvalued?

See the intrinsic value estimate for Avacta Group PLC and find out whether today’s valuation is cheap or expensive by its own historical standards.

Do our valuations actually work? See backtest results .

AVCT Intrinsic Value
LOCKED
Unlock
Today vs. history

AVCT looks overvalued.
But is it expensive by its own standards?

See how today’s valuation compares with AVCT’s past valuations and how the stock performed after similar periods.

See what happened next Free account required
Monitor AVCT
Get notified when the price drops
Track Buy Zone
20% below Intrinsic Value
Get notified when the price drops into your buy zone
Current Price 63.3
Intrinsic Value Locked
Margin of Safety 20% Locked
Or choose another margin of safety
0% below Intrinsic Value
10% below Intrinsic Value
30% below Intrinsic Value
40% below Intrinsic Value
50% below Intrinsic Value
Custom
Alternatives to AVCT

Fundamental Analysis

What Avacta Group Does

Biotechnology Health Care

Avacta Group is a life sciences company built around its proprietary Affimer technology, which creates small binding proteins used in diagnostics and drug development. In simple terms, it makes tools that can recognize specific biological targets and then sells or licenses those tools for research, testing, and therapeutic work.

Headquarters
United Kingdom UK
Employees
151
IPO date
Sep 8, 2003
Read the full company overview
View Company Overview
Financials
Efficiency

Earnings Waterfall
Avacta Group PLC

Wall St Price Targets

Capital Returns

Buyback Yield
LOCKED
Debt Paydown Yield
LOCKED

Competitive Landscape

What is the Intrinsic Value of one AVCT stock?

The intrinsic value for Avacta Group PLC (AVCT) under the Base Case is hidden GBX.

Is AVCT stock undervalued or overvalued?

Compared with the current market price of 63.3 GBX, the stock appears hidden.

Back to Top